USD 94.53
(1.62%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 813.25 Million USD | -38.9% |
2022 | 1.3 Billion USD | -31.33% |
2021 | 1.72 Billion USD | 44.18% |
2020 | 1.2 Billion USD | 109.0% |
2019 | 609.55 Million USD | 15.03% |
2018 | 518.75 Million USD | 9.8% |
2017 | 424.63 Million USD | 19.08% |
2016 | 405.95 Million USD | -5.51% |
2015 | 378.63 Million USD | 21.31% |
2014 | 322.6 Million USD | -9.77% |
2013 | 331.72 Million USD | 15.46% |
2012 | 223.23 Million USD | 47.3% |
2011 | 200.05 Million USD | -16.6% |
2010 | 267.03 Million USD | 0.7% |
2009 | 200.9 Million USD | -18.03% |
2008 | 262.64 Million USD | 17.08% |
2007 | 264.88 Million USD | 23.35% |
2006 | 219.23 Million USD | -38.6% |
2005 | 287.59 Million USD | 34.54% |
2004 | 266.58 Million USD | -2.6% |
2003 | 223.51 Million USD | 24.7% |
2002 | 156.12 Million USD | -22.13% |
2001 | 200.12 Million USD | -9.46% |
2000 | 311.28 Million USD | 27.63% |
1999 | 177.5 Million USD | 197.08% |
1998 | 82.1 Million USD | -50.6% |
1997 | 166.2 Million USD | 22.3% |
1996 | 135.9 Million USD | 14.49% |
1995 | 118.7 Million USD | -29.35% |
1994 | 168 Million USD | 11.04% |
1993 | 151.3 Million USD | -1.94% |
1992 | 154.3 Million USD | -0.39% |
1991 | 154.9 Million USD | 21.39% |
1990 | 127.6 Million USD | 12.52% |
1989 | 113.4 Million USD | -2.07% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 151.91 Million USD | -5.77% |
2024 Q3 | 59.81 Million USD | 6.31% |
2024 Q2 | 208.76 Million USD | 20.86% |
2023 Q4 | 182.72 Million USD | -7.69% |
2023 FY | - USD | -38.9% |
2023 Q3 | 197.93 Million USD | -5.07% |
2023 Q1 | 158.41 Million USD | -40.58% |
2023 Q2 | 208.51 Million USD | 31.62% |
2022 Q3 | 239.18 Million USD | -40.91% |
2022 Q4 | 266.62 Million USD | 11.47% |
2022 Q2 | 404.76 Million USD | 3.37% |
2022 Q1 | 391.54 Million USD | -15.88% |
2022 FY | - USD | -31.33% |
2021 Q1 | 551.24 Million USD | 0.88% |
2021 Q3 | 313.88 Million USD | -24.34% |
2021 FY | - USD | 44.18% |
2021 Q4 | 465.46 Million USD | 48.29% |
2021 Q2 | 414.87 Million USD | -24.74% |
2020 Q2 | 236.86 Million USD | 106.02% |
2020 Q1 | 114.97 Million USD | -32.47% |
2020 Q3 | 312.34 Million USD | 31.87% |
2020 Q4 | 546.41 Million USD | 74.94% |
2020 FY | - USD | 109.0% |
2019 Q1 | 112.85 Million USD | -20.02% |
2019 Q3 | 147.26 Million USD | -1.07% |
2019 Q4 | 170.25 Million USD | 15.61% |
2019 FY | - USD | 15.03% |
2019 Q2 | 148.85 Million USD | 31.9% |
2018 Q4 | 141.1 Million USD | 5.81% |
2018 Q3 | 133.36 Million USD | 1.12% |
2018 FY | - USD | 9.8% |
2018 Q2 | 131.89 Million USD | 35.71% |
2018 Q1 | 97.18 Million USD | -20.05% |
2017 Q2 | 106.52 Million USD | 24.96% |
2017 Q4 | 121.55 Million USD | -16.34% |
2017 FY | - USD | 19.08% |
2017 Q1 | 85.24 Million USD | -19.12% |
2017 Q3 | 145.29 Million USD | 36.4% |
2016 Q4 | 105.4 Million USD | -1.91% |
2016 FY | - USD | -5.51% |
2016 Q3 | 107.45 Million USD | 5.66% |
2016 Q1 | 94.47 Million USD | -22.08% |
2016 Q2 | 101.7 Million USD | 7.65% |
2015 Q1 | 85.68 Million USD | 45.14% |
2015 Q4 | 121.24 Million USD | 20.2% |
2015 Q2 | 99.8 Million USD | 16.48% |
2015 Q3 | 100.87 Million USD | 1.07% |
2015 FY | - USD | 21.31% |
2014 Q3 | 96.73 Million USD | -2.36% |
2014 Q4 | 59.03 Million USD | -38.97% |
2014 Q2 | 99.07 Million USD | 23.47% |
2014 Q1 | 80.24 Million USD | -33.9% |
2014 FY | - USD | -9.77% |
2013 FY | - USD | 15.46% |
2013 Q3 | 91.32 Million USD | 1.22% |
2013 Q4 | 121.39 Million USD | 32.92% |
2013 Q1 | 69.43 Million USD | -12.37% |
2013 Q2 | 90.22 Million USD | 29.95% |
2012 Q4 | 79.24 Million USD | -5.21% |
2012 FY | - USD | 47.3% |
2012 Q1 | 74.75 Million USD | 188.21% |
2012 Q2 | 87.29 Million USD | 16.77% |
2012 Q3 | 83.59 Million USD | -4.24% |
2011 Q2 | 67.96 Million USD | 6.83% |
2011 FY | - USD | -16.6% |
2011 Q4 | 25.93 Million USD | -58.74% |
2011 Q3 | 62.87 Million USD | -7.49% |
2011 Q1 | 63.61 Million USD | -21.49% |
2010 Q1 | 63.21 Million USD | -24.14% |
2010 Q2 | 77.56 Million USD | 22.7% |
2010 Q3 | 58.96 Million USD | -23.99% |
2010 FY | - USD | 0.7% |
2010 Q4 | 81.03 Million USD | 37.44% |
2009 Q4 | 83.33 Million USD | 34.14% |
2009 Q1 | 55.64 Million USD | -47.17% |
2009 FY | - USD | -18.03% |
2009 Q2 | 60.39 Million USD | 8.54% |
2009 Q3 | 62.12 Million USD | 2.86% |
2008 FY | - USD | 17.08% |
2008 Q1 | 59.1 Million USD | -32.06% |
2008 Q2 | 69.58 Million USD | 17.73% |
2008 Q3 | 84.04 Million USD | 20.78% |
2008 Q4 | 105.33 Million USD | 25.34% |
2007 FY | - USD | 23.35% |
2007 Q2 | 62.68 Million USD | 9.43% |
2007 Q1 | 57.28 Million USD | -15.24% |
2007 Q3 | 64.7 Million USD | 3.23% |
2007 Q4 | 86.99 Million USD | 34.44% |
2006 Q4 | 67.58 Million USD | 25.94% |
2006 Q2 | 52.55 Million USD | 13.18% |
2006 Q1 | 46.43 Million USD | -74.59% |
2006 FY | - USD | -38.6% |
2006 Q3 | 53.66 Million USD | 2.11% |
2005 FY | - USD | 34.54% |
2005 Q4 | 182.75 Million USD | 235.02% |
2005 Q3 | 54.54 Million USD | -31.82% |
2005 Q2 | 80 Million USD | 42.78% |
2005 Q1 | 56.03 Million USD | -39.27% |
2004 Q1 | 51.18 Million USD | -61.3% |
2004 Q2 | 59.51 Million USD | 16.28% |
2004 Q3 | 61.44 Million USD | 3.24% |
2004 FY | - USD | -2.6% |
2004 Q4 | 92.26 Million USD | 50.15% |
2003 Q1 | 40.49 Million USD | -43.26% |
2003 Q4 | 77.04 Million USD | 138.56% |
2003 Q3 | 55.44 Million USD | 17.89% |
2003 Q2 | 50.35 Million USD | -11.77% |
2003 FY | - USD | 24.7% |
2002 Q2 | 41.04 Million USD | 229.02% |
2002 Q4 | 61.36 Million USD | 91.84% |
2002 FY | - USD | -22.13% |
2002 Q3 | 48.96 Million USD | 19.28% |
2002 Q1 | -2.85 Million USD | -86.75% |
2001 Q3 | 73.89 Million USD | -38.09% |
2001 Q4 | 31.63 Million USD | 86.94% |
2001 FY | - USD | -9.46% |
2001 Q1 | 79.56 Million USD | 12.9% |
2001 Q2 | 81.36 Million USD | 1.34% |
2000 Q1 | 65.34 Million USD | -14.29% |
2000 FY | - USD | 27.63% |
2000 Q4 | 71.12 Million USD | -34.46% |
2000 Q3 | 47.22 Million USD | 72.75% |
2000 Q2 | 59.56 Million USD | -8.73% |
1999 Q2 | 55 Million USD | 32.21% |
1999 Q1 | 41.6 Million USD | -25.18% |
1999 FY | - USD | 197.08% |
1999 Q4 | 80.3 Million USD | 6.92% |
1999 Q3 | 75.1 Million USD | 36.55% |
1998 Q1 | -3.9 Million USD | -108.42% |
1998 Q2 | 2.3 Million USD | 158.97% |
1998 Q4 | 55.6 Million USD | 97.16% |
1998 Q3 | 22 Million USD | 1126.09% |
1998 FY | - USD | -50.6% |
1997 Q2 | 59.3 Million USD | 102.39% |
1997 FY | - USD | 22.3% |
1997 Q4 | 46.3 Million USD | 47.92% |
1997 Q3 | 31.3 Million USD | -47.22% |
1997 Q1 | 29.3 Million USD | -19.51% |
1996 Q2 | 31.7 Million USD | 2.59% |
1996 Q1 | 30.9 Million USD | -14.88% |
1996 FY | - USD | 14.49% |
1996 Q4 | 36.4 Million USD | -1.62% |
1996 Q3 | 37 Million USD | 16.72% |
1995 FY | - USD | -29.35% |
1995 Q4 | 36.3 Million USD | 32.0% |
1995 Q3 | 27.5 Million USD | -10.13% |
1995 Q2 | 30.6 Million USD | 33.04% |
1995 Q1 | 23 Million USD | -86.56% |
1994 FY | - USD | 11.04% |
1994 Q4 | 171.1 Million USD | 481.07% |
1994 Q2 | 33.7 Million USD | 13.09% |
1994 Q1 | 29.8 Million USD | -24.94% |
1994 Q3 | -44.9 Million USD | -233.23% |
1993 Q2 | 39.2 Million USD | 3.7% |
1993 Q3 | 34.7 Million USD | -11.48% |
1993 Q4 | 39.7 Million USD | 14.41% |
1993 FY | - USD | -1.94% |
1993 Q1 | 37.8 Million USD | 3.28% |
1992 Q4 | 36.6 Million USD | -9.41% |
1992 FY | - USD | -0.39% |
1992 Q1 | 34.6 Million USD | -20.82% |
1992 Q3 | 40.4 Million USD | -5.39% |
1992 Q2 | 42.7 Million USD | 23.41% |
1991 Q1 | 32.2 Million USD | -15.71% |
1991 Q3 | 41 Million USD | 8.18% |
1991 Q4 | 43.7 Million USD | 6.59% |
1991 FY | - USD | 21.39% |
1991 Q2 | 37.9 Million USD | 17.7% |
1990 Q1 | 28.8 Million USD | -2.7% |
1990 Q2 | 28.7 Million USD | -0.35% |
1990 FY | - USD | 12.52% |
1990 Q3 | 31.8 Million USD | 10.8% |
1990 Q4 | 38.2 Million USD | 20.13% |
1989 FY | - USD | -2.07% |
1989 Q1 | 390.9 Million USD | 142.4% |
1989 Q2 | 32.7 Million USD | -91.63% |
1989 Q3 | 25.7 Million USD | -21.41% |
1989 Q4 | 36.2 Million USD | 15.18% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Agilent Technologies, Inc. | 1.67 Billion USD | 51.505% |
Charles River Laboratories International, Inc. | 1.03 Billion USD | 21.205% |
Quest Diagnostics Incorporated | 1.73 Billion USD | 53.045% |
Danaher Corporation | 7.54 Billion USD | 89.224% |
Enzo Biochem, Inc. | -8.34 Million USD | 9841.89% |
IQVIA Holdings Inc. | 3.25 Billion USD | 75.023% |
Laboratory Corporation of America Holdings | 1.34 Billion USD | 39.732% |
Mettler-Toledo International Inc. | 1.18 Billion USD | 31.264% |
Qiagen N.V. | 650.58 Million USD | -25.004% |
Thermo Fisher Scientific Inc. | 10.8 Billion USD | 92.47% |
Waters Corporation | 1.02 Billion USD | 20.445% |